Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$42.51 - $63.78 $174,503 - $261,816
-4,105 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $224,914 - $299,240
-4,965 Reduced 54.74%
4,105 $232,000
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $546,481 - $724,995
-11,517 Reduced 55.94%
9,070 $430,000
Q2 2020

Aug 13, 2020

BUY
$46.85 - $61.05 $964,500 - $1.26 Million
20,587 New
20,587 $1.21 Million
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $426,108 - $649,406
-10,243 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$53.85 - $65.27 $551,585 - $668,560
10,243 New
10,243 $619,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Athanor Capital, LP Portfolio

Follow Athanor Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Athanor Capital, LP with notifications on news.